Global AI for Pharma and Biotech Market Research Report 2022
Global AI for Pharma and Biotech Market Overview:
Global AI for Pharma and Biotech Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of AI for Pharma and Biotech involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the AI for Pharma and Biotech Market
The AI for Pharma and Biotech Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for AI for Pharma and Biotech Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study AI for Pharma and Biotech Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on AI for Pharma and Biotech Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the AI for Pharma and Biotech market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global AI for Pharma and Biotech Market Segmentation
Global AI for Pharma and Biotech Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, AI for Pharma and Biotech market has been segmented into:
Software
Services
By Application, AI for Pharma and Biotech market has been segmented into:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers
Academic & Government Institutes
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The AI for Pharma and Biotech market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the AI for Pharma and Biotech market.
Top Key Players Covered in AI for Pharma and Biotech market are:
Cloud Pharmaceuticals Inc
IBM Corporation
Microsoft
Insilico Medicine
DEEP GENOMICS
Atomwise Inc
Exscientia
BenevolentAI Ltd
NVIDIA Corporation
Cyclica Inc
Objective to buy this Report:
1. AI for Pharma and Biotech analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with AI for Pharma and Biotech market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global AI for Pharma and Biotech Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of AI for Pharma and Biotech involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the AI for Pharma and Biotech Market
The AI for Pharma and Biotech Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for AI for Pharma and Biotech Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study AI for Pharma and Biotech Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on AI for Pharma and Biotech Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the AI for Pharma and Biotech market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global AI for Pharma and Biotech Market Segmentation
Global AI for Pharma and Biotech Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, AI for Pharma and Biotech market has been segmented into:
Software
Services
By Application, AI for Pharma and Biotech market has been segmented into:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers
Academic & Government Institutes
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The AI for Pharma and Biotech market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the AI for Pharma and Biotech market.
Top Key Players Covered in AI for Pharma and Biotech market are:
Cloud Pharmaceuticals Inc
IBM Corporation
Microsoft
Insilico Medicine
DEEP GENOMICS
Atomwise Inc
Exscientia
BenevolentAI Ltd
NVIDIA Corporation
Cyclica Inc
Objective to buy this Report:
1. AI for Pharma and Biotech analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with AI for Pharma and Biotech market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 RESEARCH OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.3 RESEARCH PROCESS
1.4 SCOPE AND COVERAGE
1.4.1 MARKET DEFINITION
1.4.2 KEY QUESTIONS ANSWERED
1.5 MARKET SEGMENTATION
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 BY TYPE
3.2 BY APPLICATION
CHAPTER 4: MARKET LANDSCAPE
4.1 PORTER'S FIVE FORCES ANALYSIS
4.1.1 BARGAINING POWER OF SUPPLIER
4.1.2 THREAT OF NEW ENTRANTS
4.1.3 THREAT OF SUBSTITUTES
4.1.4 COMPETITIVE RIVALRY
4.1.5 BARGAINING POWER AMONG BUYERS
4.2 INDUSTRY VALUE CHAIN ANALYSIS
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 OPPORTUNITIES
4.5.4 CHALLENGES
4.4 PESTLE ANALYSIS
4.5 TECHNOLOGICAL ROADMAP
4.6 REGULATORY LANDSCAPE
4.7 SWOT ANALYSIS
4.8 PRICE TREND ANALYSIS
4.9 PATENT ANALYSIS
4.10 ANALYSIS OF THE IMPACT OF COVID-19
4.10.1 IMPACT ON THE OVERALL MARKET
4.10.2 IMPACT ON THE SUPPLY CHAIN
4.10.3 IMPACT ON THE KEY MANUFACTURERS
4.10.4 IMPACT ON THE PRICING
CHAPTER 5: AI FOR PHARMA AND BIOTECH MARKET BY TYPE
5.1 AI FOR PHARMA AND BIOTECH MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
5.2 AI FOR PHARMA AND BIOTECH MARKET OVERVIEW
5.3 SOFTWARE
5.3.1 INTRODUCTION AND MARKET OVERVIEW
5.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.3.4 SOFTWARE: GEOGRAPHIC SEGMENTATION
5.4 SERVICES
5.4.1 INTRODUCTION AND MARKET OVERVIEW
5.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.4.4 SERVICES: GEOGRAPHIC SEGMENTATION
CHAPTER 6: AI FOR PHARMA AND BIOTECH MARKET BY APPLICATION
6.1 AI FOR PHARMA AND BIOTECH MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
6.2 AI FOR PHARMA AND BIOTECH MARKET OVERVIEW
6.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
6.3.1 INTRODUCTION AND MARKET OVERVIEW
6.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.3.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: GEOGRAPHIC SEGMENTATION
6.4 CONTRACT RESEARCH ORGANIZATIONS
6.4.1 INTRODUCTION AND MARKET OVERVIEW
6.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.4.4 CONTRACT RESEARCH ORGANIZATIONS: GEOGRAPHIC SEGMENTATION
6.5 RESEARCH CENTERS
6.5.1 INTRODUCTION AND MARKET OVERVIEW
6.5.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.5.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.5.4 RESEARCH CENTERS: GEOGRAPHIC SEGMENTATION
6.6 ACADEMIC & GOVERNMENT INSTITUTES
6.6.1 INTRODUCTION AND MARKET OVERVIEW
6.6.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.6.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.6.4 ACADEMIC & GOVERNMENT INSTITUTES: GEOGRAPHIC SEGMENTATION
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 COMPETITIVE LANDSCAPE
7.1.1 COMPETITIVE POSITIONING
7.1.2 AI FOR PHARMA AND BIOTECH SALES AND MARKET SHARE BY PLAYERS
7.1.3 INDUSTRY BCG MATRIX
7.1.4 HEAT MAP ANALYSIS
7.1.5 AI FOR PHARMA AND BIOTECH INDUSTRY CONCENTRATION RATIO (CR5 AND HHI)
7.1.6 TOP 5 AI FOR PHARMA AND BIOTECH PLAYERS MARKET SHARE
7.1.7 MERGERS AND ACQUISITIONS
7.1.8 BUSINESS STRATEGIES BY TOP PLAYERS
7.2 CLOUD PHARMACEUTICALS INC
7.2.1 COMPANY OVERVIEW
7.2.2 KEY EXECUTIVES
7.2.3 COMPANY SNAPSHOT
7.2.4 OPERATING BUSINESS SEGMENTS
7.2.5 PRODUCT PORTFOLIO
7.2.6 BUSINESS PERFORMANCE
7.2.7 KEY STRATEGIC MOVES AND RECENT DEVELOPMENTS
7.2.8 SWOT ANALYSIS
7.3 IBM CORPORATION
7.4 MICROSOFT
7.5 INSILICO MEDICINE
7.6 DEEP GENOMICS
7.7 ATOMWISE INC
7.8 EXSCIENTIA
7.9 BENEVOLENTAI LTD
7.10 NVIDIA CORPORATION
7.11 CYCLICA INC
CHAPTER 8: GLOBAL AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 MARKET OVERVIEW
8.2 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
8.2.1 SOFTWARE
8.2.2 SERVICES
8.3 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
8.3.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.3.2 CONTRACT RESEARCH ORGANIZATIONS
8.3.3 RESEARCH CENTERS
8.3.4 ACADEMIC & GOVERNMENT INSTITUTES
CHAPTER 9: NORTH AMERICA AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.2 IMPACT OF COVID-19
9.3 KEY PLAYERS
9.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
9.4.1 SOFTWARE
9.4.2 SERVICES
9.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
9.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.5.2 CONTRACT RESEARCH ORGANIZATIONS
9.5.3 RESEARCH CENTERS
9.5.4 ACADEMIC & GOVERNMENT INSTITUTES
9.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
9.6.1 U.S.
9.6.2 CANADA
9.6.3 MEXICO
CHAPTER 10: EUROPE AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.2 IMPACT OF COVID-19
10.3 KEY PLAYERS
10.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
10.4.1 SOFTWARE
10.4.2 SERVICES
10.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
10.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.2 CONTRACT RESEARCH ORGANIZATIONS
10.5.3 RESEARCH CENTERS
10.5.4 ACADEMIC & GOVERNMENT INSTITUTES
10.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
10.6.1 GERMANY
10.6.2 U.K.
10.6.3 FRANCE
10.6.4 ITALY
10.6.5 RUSSIA
10.6.6 SPAIN
10.6.7 REST OF EUROPE
CHAPTER 11: ASIA-PACIFIC AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.2 IMPACT OF COVID-19
11.3 KEY PLAYERS
11.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
11.4.1 SOFTWARE
11.4.2 SERVICES
11.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
11.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.5.2 CONTRACT RESEARCH ORGANIZATIONS
11.5.3 RESEARCH CENTERS
11.5.4 ACADEMIC & GOVERNMENT INSTITUTES
11.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
11.6.1 CHINA
11.6.2 INDIA
11.6.3 JAPAN
11.6.4 SINGAPORE
11.6.5 AUSTRALIA
11.6.6 NEW ZEALAND
11.6.7 REST OF APAC
CHAPTER 12: MIDDLE EAST & AFRICA AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.2 IMPACT OF COVID-19
12.3 KEY PLAYERS
12.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
12.4.1 SOFTWARE
12.4.2 SERVICES
12.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
12.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
12.5.2 CONTRACT RESEARCH ORGANIZATIONS
12.5.3 RESEARCH CENTERS
12.5.4 ACADEMIC & GOVERNMENT INSTITUTES
12.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
12.6.1 TURKEY
12.6.2 SAUDI ARABIA
12.6.3 IRAN
12.6.4 UAE
12.6.5 AFRICA
12.6.6 REST OF MEA
CHAPTER 13: SOUTH AMERICA AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.2 IMPACT OF COVID-19
13.3 KEY PLAYERS
13.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
13.4.1 SOFTWARE
13.4.2 SERVICES
13.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
13.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.5.2 CONTRACT RESEARCH ORGANIZATIONS
13.5.3 RESEARCH CENTERS
13.5.4 ACADEMIC & GOVERNMENT INSTITUTES
13.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
13.6.1 BRAZIL
13.6.2 ARGENTINA
13.6.3 REST OF SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 RESEARCH OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.3 RESEARCH PROCESS
1.4 SCOPE AND COVERAGE
1.4.1 MARKET DEFINITION
1.4.2 KEY QUESTIONS ANSWERED
1.5 MARKET SEGMENTATION
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 BY TYPE
3.2 BY APPLICATION
CHAPTER 4: MARKET LANDSCAPE
4.1 PORTER'S FIVE FORCES ANALYSIS
4.1.1 BARGAINING POWER OF SUPPLIER
4.1.2 THREAT OF NEW ENTRANTS
4.1.3 THREAT OF SUBSTITUTES
4.1.4 COMPETITIVE RIVALRY
4.1.5 BARGAINING POWER AMONG BUYERS
4.2 INDUSTRY VALUE CHAIN ANALYSIS
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 OPPORTUNITIES
4.5.4 CHALLENGES
4.4 PESTLE ANALYSIS
4.5 TECHNOLOGICAL ROADMAP
4.6 REGULATORY LANDSCAPE
4.7 SWOT ANALYSIS
4.8 PRICE TREND ANALYSIS
4.9 PATENT ANALYSIS
4.10 ANALYSIS OF THE IMPACT OF COVID-19
4.10.1 IMPACT ON THE OVERALL MARKET
4.10.2 IMPACT ON THE SUPPLY CHAIN
4.10.3 IMPACT ON THE KEY MANUFACTURERS
4.10.4 IMPACT ON THE PRICING
CHAPTER 5: AI FOR PHARMA AND BIOTECH MARKET BY TYPE
5.1 AI FOR PHARMA AND BIOTECH MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
5.2 AI FOR PHARMA AND BIOTECH MARKET OVERVIEW
5.3 SOFTWARE
5.3.1 INTRODUCTION AND MARKET OVERVIEW
5.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.3.4 SOFTWARE: GEOGRAPHIC SEGMENTATION
5.4 SERVICES
5.4.1 INTRODUCTION AND MARKET OVERVIEW
5.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.4.4 SERVICES: GEOGRAPHIC SEGMENTATION
CHAPTER 6: AI FOR PHARMA AND BIOTECH MARKET BY APPLICATION
6.1 AI FOR PHARMA AND BIOTECH MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
6.2 AI FOR PHARMA AND BIOTECH MARKET OVERVIEW
6.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
6.3.1 INTRODUCTION AND MARKET OVERVIEW
6.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.3.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: GEOGRAPHIC SEGMENTATION
6.4 CONTRACT RESEARCH ORGANIZATIONS
6.4.1 INTRODUCTION AND MARKET OVERVIEW
6.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.4.4 CONTRACT RESEARCH ORGANIZATIONS: GEOGRAPHIC SEGMENTATION
6.5 RESEARCH CENTERS
6.5.1 INTRODUCTION AND MARKET OVERVIEW
6.5.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.5.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.5.4 RESEARCH CENTERS: GEOGRAPHIC SEGMENTATION
6.6 ACADEMIC & GOVERNMENT INSTITUTES
6.6.1 INTRODUCTION AND MARKET OVERVIEW
6.6.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.6.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.6.4 ACADEMIC & GOVERNMENT INSTITUTES: GEOGRAPHIC SEGMENTATION
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 COMPETITIVE LANDSCAPE
7.1.1 COMPETITIVE POSITIONING
7.1.2 AI FOR PHARMA AND BIOTECH SALES AND MARKET SHARE BY PLAYERS
7.1.3 INDUSTRY BCG MATRIX
7.1.4 HEAT MAP ANALYSIS
7.1.5 AI FOR PHARMA AND BIOTECH INDUSTRY CONCENTRATION RATIO (CR5 AND HHI)
7.1.6 TOP 5 AI FOR PHARMA AND BIOTECH PLAYERS MARKET SHARE
7.1.7 MERGERS AND ACQUISITIONS
7.1.8 BUSINESS STRATEGIES BY TOP PLAYERS
7.2 CLOUD PHARMACEUTICALS INC
7.2.1 COMPANY OVERVIEW
7.2.2 KEY EXECUTIVES
7.2.3 COMPANY SNAPSHOT
7.2.4 OPERATING BUSINESS SEGMENTS
7.2.5 PRODUCT PORTFOLIO
7.2.6 BUSINESS PERFORMANCE
7.2.7 KEY STRATEGIC MOVES AND RECENT DEVELOPMENTS
7.2.8 SWOT ANALYSIS
7.3 IBM CORPORATION
7.4 MICROSOFT
7.5 INSILICO MEDICINE
7.6 DEEP GENOMICS
7.7 ATOMWISE INC
7.8 EXSCIENTIA
7.9 BENEVOLENTAI LTD
7.10 NVIDIA CORPORATION
7.11 CYCLICA INC
CHAPTER 8: GLOBAL AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 MARKET OVERVIEW
8.2 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
8.2.1 SOFTWARE
8.2.2 SERVICES
8.3 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
8.3.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.3.2 CONTRACT RESEARCH ORGANIZATIONS
8.3.3 RESEARCH CENTERS
8.3.4 ACADEMIC & GOVERNMENT INSTITUTES
CHAPTER 9: NORTH AMERICA AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.2 IMPACT OF COVID-19
9.3 KEY PLAYERS
9.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
9.4.1 SOFTWARE
9.4.2 SERVICES
9.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
9.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.5.2 CONTRACT RESEARCH ORGANIZATIONS
9.5.3 RESEARCH CENTERS
9.5.4 ACADEMIC & GOVERNMENT INSTITUTES
9.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
9.6.1 U.S.
9.6.2 CANADA
9.6.3 MEXICO
CHAPTER 10: EUROPE AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.2 IMPACT OF COVID-19
10.3 KEY PLAYERS
10.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
10.4.1 SOFTWARE
10.4.2 SERVICES
10.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
10.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.2 CONTRACT RESEARCH ORGANIZATIONS
10.5.3 RESEARCH CENTERS
10.5.4 ACADEMIC & GOVERNMENT INSTITUTES
10.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
10.6.1 GERMANY
10.6.2 U.K.
10.6.3 FRANCE
10.6.4 ITALY
10.6.5 RUSSIA
10.6.6 SPAIN
10.6.7 REST OF EUROPE
CHAPTER 11: ASIA-PACIFIC AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.2 IMPACT OF COVID-19
11.3 KEY PLAYERS
11.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
11.4.1 SOFTWARE
11.4.2 SERVICES
11.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
11.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.5.2 CONTRACT RESEARCH ORGANIZATIONS
11.5.3 RESEARCH CENTERS
11.5.4 ACADEMIC & GOVERNMENT INSTITUTES
11.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
11.6.1 CHINA
11.6.2 INDIA
11.6.3 JAPAN
11.6.4 SINGAPORE
11.6.5 AUSTRALIA
11.6.6 NEW ZEALAND
11.6.7 REST OF APAC
CHAPTER 12: MIDDLE EAST & AFRICA AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.2 IMPACT OF COVID-19
12.3 KEY PLAYERS
12.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
12.4.1 SOFTWARE
12.4.2 SERVICES
12.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
12.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
12.5.2 CONTRACT RESEARCH ORGANIZATIONS
12.5.3 RESEARCH CENTERS
12.5.4 ACADEMIC & GOVERNMENT INSTITUTES
12.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
12.6.1 TURKEY
12.6.2 SAUDI ARABIA
12.6.3 IRAN
12.6.4 UAE
12.6.5 AFRICA
12.6.6 REST OF MEA
CHAPTER 13: SOUTH AMERICA AI FOR PHARMA AND BIOTECH MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.2 IMPACT OF COVID-19
13.3 KEY PLAYERS
13.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
13.4.1 SOFTWARE
13.4.2 SERVICES
13.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
13.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.5.2 CONTRACT RESEARCH ORGANIZATIONS
13.5.3 RESEARCH CENTERS
13.5.4 ACADEMIC & GOVERNMENT INSTITUTES
13.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
13.6.1 BRAZIL
13.6.2 ARGENTINA
13.6.3 REST OF SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. AI FOR PHARMA AND BIOTECH MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. AI FOR PHARMA AND BIOTECH MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. AI FOR PHARMA AND BIOTECH MARKET COMPETITIVE RIVALRY
TABLE 005. AI FOR PHARMA AND BIOTECH MARKET THREAT OF NEW ENTRANTS
TABLE 006. AI FOR PHARMA AND BIOTECH MARKET THREAT OF SUBSTITUTES
TABLE 007. AI FOR PHARMA AND BIOTECH MARKET BY TYPE
TABLE 008. SOFTWARE MARKET OVERVIEW (2016-2028)
TABLE 009. SERVICES MARKET OVERVIEW (2016-2028)
TABLE 010. AI FOR PHARMA AND BIOTECH MARKET BY APPLICATION
TABLE 011. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 012. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
TABLE 013. RESEARCH CENTERS MARKET OVERVIEW (2016-2028)
TABLE 014. ACADEMIC & GOVERNMENT INSTITUTES MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 016. NORTH AMERICA AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 017. N AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 019. EUROPE AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 020. AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 022. ASIA PACIFIC AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 023. AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 026. AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 028. SOUTH AMERICA AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 029. AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 030. CLOUD PHARMACEUTICALS INC: SNAPSHOT
TABLE 031. CLOUD PHARMACEUTICALS INC: BUSINESS PERFORMANCE
TABLE 032. CLOUD PHARMACEUTICALS INC: PRODUCT PORTFOLIO
TABLE 033. CLOUD PHARMACEUTICALS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. IBM CORPORATION: SNAPSHOT
TABLE 034. IBM CORPORATION: BUSINESS PERFORMANCE
TABLE 035. IBM CORPORATION: PRODUCT PORTFOLIO
TABLE 036. IBM CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. MICROSOFT: SNAPSHOT
TABLE 037. MICROSOFT: BUSINESS PERFORMANCE
TABLE 038. MICROSOFT: PRODUCT PORTFOLIO
TABLE 039. MICROSOFT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. INSILICO MEDICINE: SNAPSHOT
TABLE 040. INSILICO MEDICINE: BUSINESS PERFORMANCE
TABLE 041. INSILICO MEDICINE: PRODUCT PORTFOLIO
TABLE 042. INSILICO MEDICINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. DEEP GENOMICS: SNAPSHOT
TABLE 043. DEEP GENOMICS: BUSINESS PERFORMANCE
TABLE 044. DEEP GENOMICS: PRODUCT PORTFOLIO
TABLE 045. DEEP GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. ATOMWISE INC: SNAPSHOT
TABLE 046. ATOMWISE INC: BUSINESS PERFORMANCE
TABLE 047. ATOMWISE INC: PRODUCT PORTFOLIO
TABLE 048. ATOMWISE INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. EXSCIENTIA: SNAPSHOT
TABLE 049. EXSCIENTIA: BUSINESS PERFORMANCE
TABLE 050. EXSCIENTIA: PRODUCT PORTFOLIO
TABLE 051. EXSCIENTIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. BENEVOLENTAI LTD: SNAPSHOT
TABLE 052. BENEVOLENTAI LTD: BUSINESS PERFORMANCE
TABLE 053. BENEVOLENTAI LTD: PRODUCT PORTFOLIO
TABLE 054. BENEVOLENTAI LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. NVIDIA CORPORATION: SNAPSHOT
TABLE 055. NVIDIA CORPORATION: BUSINESS PERFORMANCE
TABLE 056. NVIDIA CORPORATION: PRODUCT PORTFOLIO
TABLE 057. NVIDIA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. CYCLICA INC: SNAPSHOT
TABLE 058. CYCLICA INC: BUSINESS PERFORMANCE
TABLE 059. CYCLICA INC: PRODUCT PORTFOLIO
TABLE 060. CYCLICA INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. AI FOR PHARMA AND BIOTECH MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. AI FOR PHARMA AND BIOTECH MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. AI FOR PHARMA AND BIOTECH MARKET COMPETITIVE RIVALRY
TABLE 005. AI FOR PHARMA AND BIOTECH MARKET THREAT OF NEW ENTRANTS
TABLE 006. AI FOR PHARMA AND BIOTECH MARKET THREAT OF SUBSTITUTES
TABLE 007. AI FOR PHARMA AND BIOTECH MARKET BY TYPE
TABLE 008. SOFTWARE MARKET OVERVIEW (2016-2028)
TABLE 009. SERVICES MARKET OVERVIEW (2016-2028)
TABLE 010. AI FOR PHARMA AND BIOTECH MARKET BY APPLICATION
TABLE 011. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 012. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
TABLE 013. RESEARCH CENTERS MARKET OVERVIEW (2016-2028)
TABLE 014. ACADEMIC & GOVERNMENT INSTITUTES MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 016. NORTH AMERICA AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 017. N AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 019. EUROPE AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 020. AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 022. ASIA PACIFIC AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 023. AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 026. AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA AI FOR PHARMA AND BIOTECH MARKET, BY TYPE (2016-2028)
TABLE 028. SOUTH AMERICA AI FOR PHARMA AND BIOTECH MARKET, BY APPLICATION (2016-2028)
TABLE 029. AI FOR PHARMA AND BIOTECH MARKET, BY COUNTRY (2016-2028)
TABLE 030. CLOUD PHARMACEUTICALS INC: SNAPSHOT
TABLE 031. CLOUD PHARMACEUTICALS INC: BUSINESS PERFORMANCE
TABLE 032. CLOUD PHARMACEUTICALS INC: PRODUCT PORTFOLIO
TABLE 033. CLOUD PHARMACEUTICALS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. IBM CORPORATION: SNAPSHOT
TABLE 034. IBM CORPORATION: BUSINESS PERFORMANCE
TABLE 035. IBM CORPORATION: PRODUCT PORTFOLIO
TABLE 036. IBM CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. MICROSOFT: SNAPSHOT
TABLE 037. MICROSOFT: BUSINESS PERFORMANCE
TABLE 038. MICROSOFT: PRODUCT PORTFOLIO
TABLE 039. MICROSOFT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. INSILICO MEDICINE: SNAPSHOT
TABLE 040. INSILICO MEDICINE: BUSINESS PERFORMANCE
TABLE 041. INSILICO MEDICINE: PRODUCT PORTFOLIO
TABLE 042. INSILICO MEDICINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. DEEP GENOMICS: SNAPSHOT
TABLE 043. DEEP GENOMICS: BUSINESS PERFORMANCE
TABLE 044. DEEP GENOMICS: PRODUCT PORTFOLIO
TABLE 045. DEEP GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. ATOMWISE INC: SNAPSHOT
TABLE 046. ATOMWISE INC: BUSINESS PERFORMANCE
TABLE 047. ATOMWISE INC: PRODUCT PORTFOLIO
TABLE 048. ATOMWISE INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. EXSCIENTIA: SNAPSHOT
TABLE 049. EXSCIENTIA: BUSINESS PERFORMANCE
TABLE 050. EXSCIENTIA: PRODUCT PORTFOLIO
TABLE 051. EXSCIENTIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. BENEVOLENTAI LTD: SNAPSHOT
TABLE 052. BENEVOLENTAI LTD: BUSINESS PERFORMANCE
TABLE 053. BENEVOLENTAI LTD: PRODUCT PORTFOLIO
TABLE 054. BENEVOLENTAI LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. NVIDIA CORPORATION: SNAPSHOT
TABLE 055. NVIDIA CORPORATION: BUSINESS PERFORMANCE
TABLE 056. NVIDIA CORPORATION: PRODUCT PORTFOLIO
TABLE 057. NVIDIA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. CYCLICA INC: SNAPSHOT
TABLE 058. CYCLICA INC: BUSINESS PERFORMANCE
TABLE 059. CYCLICA INC: PRODUCT PORTFOLIO
TABLE 060. CYCLICA INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY TYPE
FIGURE 012. SOFTWARE MARKET OVERVIEW (2016-2028)
FIGURE 013. SERVICES MARKET OVERVIEW (2016-2028)
FIGURE 014. AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY APPLICATION
FIGURE 015. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 016. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
FIGURE 017. RESEARCH CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 018. ACADEMIC & GOVERNMENT INSTITUTES MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY TYPE
FIGURE 012. SOFTWARE MARKET OVERVIEW (2016-2028)
FIGURE 013. SERVICES MARKET OVERVIEW (2016-2028)
FIGURE 014. AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY APPLICATION
FIGURE 015. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 016. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
FIGURE 017. RESEARCH CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 018. ACADEMIC & GOVERNMENT INSTITUTES MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA AI FOR PHARMA AND BIOTECH MARKET OVERVIEW BY COUNTRY (2016-2028)
